| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/18/2013 | CA2546637C Colonic purgative composition with soluble binding agent |
| 06/18/2013 | CA2483102C Treatment and prevention of pulmonary conditions |
| 06/18/2013 | CA2475923C Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 06/18/2013 | CA2468463C Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 06/18/2013 | CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/18/2013 | CA2267077C Methods for treating skin pigmentation |
| 06/13/2013 | WO2013086094A1 Broad spectrum natural preservative composition |
| 06/13/2013 | WO2013085902A1 Combination therapy methods for treating an inflammatory breast cancer |
| 06/13/2013 | WO2013084578A1 Evaluation method, screening method, antipruritic substance, and antipruritic agent |
| 06/13/2013 | WO2013083826A2 Glp-1 agonists |
| 06/13/2013 | WO2013083286A1 TREATMENT OF ARTERIAL WALL BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR |
| 06/13/2013 | WO2009108755A3 Pharmaceutical combinations for the treatment of cancer |
| 06/13/2013 | US20130150649 Sensitization of tumor cells to radiation therapy through administration of endothelin agonists |
| 06/13/2013 | US20130150442 Oligo-benzamide compounds and their use in treating cancers |
| 06/13/2013 | US20130150440 Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers |
| 06/13/2013 | US20130150437 Naphthoquinones for disease therapies |
| 06/13/2013 | US20130150432 Efficacy of cancer therapy |
| 06/13/2013 | US20130150425 Antisense modulation of gccr expression |
| 06/13/2013 | US20130150399 Inhibitors of the unfolded protein response and methods for their use |
| 06/13/2013 | US20130150391 Piperidinyl Pyrimidine Amides As KV7 Potassium Channel Openers |
| 06/13/2013 | US20130150386 Methods for the treatment of lung cancer |
| 06/13/2013 | US20130150381 Phenylthioacetate compounds, compositions and methods of use |
| 06/13/2013 | US20130150376 Novel Sultam Compounds |
| 06/13/2013 | US20130150375 GEPIRONE-ER TREATMENT OF MAJOR DEPRESSION IN PATIENTS TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) |
| 06/13/2013 | US20130150369 Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis |
| 06/13/2013 | US20130150362 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 06/13/2013 | US20130150359 Pyrazoloquinolines |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130150330 Decoquinate prodrugs |
| 06/13/2013 | US20130150325 3-(Fluorovinyl)pyrazoles and their use |
| 06/13/2013 | US20130150321 Acetaminophen/Ibuprofen Combinations And Method For Their Use |
| 06/13/2013 | US20130150309 Cyclized peptidomimetic small molecule inhibitors of the wdr5 and mll1 interaction |
| 06/13/2013 | US20130150302 Conjugated blood coagulation factor viii |
| 06/13/2013 | US20130150301 Therapeutic agents for regulating serum phosphorus |
| 06/13/2013 | US20130150293 Method for preventing and treating diabetes using neurturin |
| 06/13/2013 | US20130150292 Soft Protease Inhibitors and Pro-Soft Forms Thereof |
| 06/13/2013 | US20130149356 Muscle-based grafts/implants |
| 06/13/2013 | US20130149345 Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| 06/13/2013 | US20130149339 Composition for inducing proliferation or accumulation of regulatory t cells |
| 06/13/2013 | US20130149338 Compositions and methods for rapid immunization against dengue virus |
| 06/13/2013 | US20130149320 Asf1b as a Prognosis Marker and Therapeutic Target in Human Cancer |
| 06/13/2013 | US20130149307 Humanized anti-egfl7 antibodies and methods using same |
| 06/13/2013 | US20130149299 Dosages for treatment with anti-egfr antibodies |
| 06/13/2013 | US20130149298 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin |
| 06/13/2013 | US20130149296 Salts of Isophosphoramide Mustard and Analogs Thereof As Anti-Tumor Agents |
| 06/13/2013 | US20130149295 Furin and biologically active derivatives thereof for use in the prevention or treatment of an inflammatory disease |
| 06/13/2013 | US20130149283 Methods and compositions for treating hepatitis c virus |
| 06/13/2013 | US20130149281 Organic compounds and their uses |
| 06/13/2013 | US20130149280 Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation |
| 06/13/2013 | US20130149257 Antimicrobial compositions |
| 06/13/2013 | US20130149238 Anti-VEGF Antibody Compositions and Methods |
| 06/13/2013 | US20130149236 Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof |
| 06/12/2013 | EP2602618A1 Method for screening chronic inflammation suppression agent or cancer metastasis suppression agent having inhibition of bonding of emmprin and s100a9 as indicator |
| 06/12/2013 | EP2602322A1 Induction of exon skipping in eukaryotic cells |
| 06/12/2013 | EP2601971A1 Composition for regeneratng normal tissue from fibrotic tissue |
| 06/12/2013 | EP2601953A1 Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 06/12/2013 | EP2601949A2 Pharmaceutical compositions |
| 06/12/2013 | EP2601947A1 Fixed-dose combination for treatment of helicobacter pylori associated diseases |
| 06/12/2013 | EP2601938A1 Pharmaceutical compositions for the treatment of Helicobacter pylori associated diseases |
| 06/12/2013 | EP2600861A1 Use of teriflunomide for treating multiple sclerosis |
| 06/12/2013 | EP2600855A2 Combination therapy for the treatment of prostate carcinoma |
| 06/12/2013 | EP2600835A1 Combinations of hepatitis c virus inhibitors |
| 06/12/2013 | CN1921885B Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
| 06/12/2013 | CN1668305B Microbicidal pyrimidine or triazine for preventing sexual HIV transmission |
| 06/12/2013 | CN1461310B ANtibodies that bind human interleukin-18 and methods of making and using |
| 06/12/2013 | CN103153313A Compositions for treating heartworm infestation |
| 06/12/2013 | CN103153304A Compositions for treating helicobacter pylori infection |
| 06/12/2013 | CN103153292A Combination anti-cancer therapy |
| 06/12/2013 | CN103143031A Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers |
| 06/12/2013 | CN103143027A Preparation of hyaluronic-acid-based double-targeting nano-composite medicament and application of double-targeting nano-composite medicament |
| 06/12/2013 | CN103143024A Implantable kidney-tonifying bone-invigorating traditional Chinese medicine extract-antibiotic-calcium sulfate sustained-release system, and preparation method and application thereof |
| 06/12/2013 | CN103143023A Alpha 7 nicotinic agonists and antipsychotics |
| 06/12/2013 | CN103143022A Ophthalmologic irrigation solutions and method |
| 06/12/2013 | CN103143021A Application of PPAR alpha-UGT (peroxisome proliferator activated receptor alpha-uridine diphosphate glucuronosyl transferase) pathway inhibitor in treating inflammatory bowel diseases |
| 06/12/2013 | CN103143020A Pharmaceutical composition for treating hypertensive left ventricular hypertrophy and application thereof |
| 06/12/2013 | CN103143019A Compound preparation for treating porcine contagious pleuropneumonia and respiratory tract mixed infection and preparation method thereof |
| 06/12/2013 | CN103143018A Oral formulations containing metformin and alpha-glycosidase inhibitor, and preparation method thereof |
| 06/12/2013 | CN103143017A VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 06/12/2013 | CN103143016A Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing |
| 06/12/2013 | CN103143004A Survivin peptide vaccine |
| 06/12/2013 | CN103142999A Compositions and methods for treatment of microbial disorders |
| 06/12/2013 | CN103142594A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 06/12/2013 | CN103142492A Controlled release pellet preparation and its preparation method |
| 06/12/2013 | CN103142458A Component and preparation method of non-addition analgesia slow release medicine delivering system |
| 06/12/2013 | CN102397547B Anti-cancer pharmaceutical composition |
| 06/12/2013 | CN102335429B Tumor inhibiting medicine composition and purpose thereof |
| 06/12/2013 | CN102276606B Tosylate crystalline salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor |
| 06/12/2013 | CN102209539B P70 S6 kinase inhibitor and MTOR inhibitor combination therapy |
| 06/12/2013 | CN102209538B P70 S6 kinase inhibitor and EGFR inhibitor combination therapy |
| 06/12/2013 | CN102133402B Application of cystic fibrosis transmembrane transduction regulating factor inhibitor to preparation of medicaments for treating diabetes |
| 06/12/2013 | CN102088969B Combination of spacitabine (CNDAC) and DNA methyltransferase inhibitors such as decitabine and procaine |
| 06/12/2013 | CN101983072B Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 06/12/2013 | CN101766299B Immune regulation composite |
| 06/12/2013 | CN101678031B Formulations containing triazinones and iron |
| 06/12/2013 | CN101094689B Treatment of obesity and related disorders |
| 06/12/2013 | CN101018546B (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/11/2013 | US8461410 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 06/11/2013 | US8461143 Stabilizing compositions for antibiotics and methods of use |
| 06/11/2013 | US8461137 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| 06/11/2013 | US8461136 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |